- 专利标题： Tricyclic pyridone compounds as JAK2 V617F inhibitors
-
申请号： US17365686申请日： 2021-07-01
-
公开(公告)号： US11767323B2公开(公告)日： 2023-09-26
- 发明人: Kai Liu , Onur Atasoylu , Yu Bai , Andrew W. Buesking , Leah C. Konkol , Cheng-Tsung Lai , Song Mei , Jun Pan , Liangxing Wu , Wenqing Yao
- 申请人： Incyte Corporation
- 申请人地址： US DE Wilmington
- 专利权人： Incyte Corporation
- 当前专利权人： Incyte Corporation
- 当前专利权人地址： US DE Wilmington
- 代理机构： Fish & Richardson P.C.
- 主分类号： C07D471/14
- IPC分类号： C07D471/14 ; A61K31/437 ; C07D519/00
摘要：
The present application provides tricyclic pyridone compounds that modulate the activity of the V617F variant of JAK2, which are useful in the treatment of various diseases, including cancer.
公开/授权文献
- US20220002299A1 TRICYCLIC PYRIDONE COMPOUNDS AS JAK2 V617F INHIBITORS 公开/授权日：2022-01-06
信息查询
